Seladelpar and liraglutide alone or seladelpar in combination with liraglutide or selonsertib resulted in significant reductions in plasma ALT and AST levels compared with the NASH Vehicle. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.